http://dbpedia.org/ontology/abstract
|
JNJ-7777120 was a drug being developed by … JNJ-7777120 was a drug being developed by Johnson & Johnson Pharmaceutical Research & Development which acts as a potent and selective antagonist at the histamine H4 receptor. It has anti-inflammatory effects, and has been demonstrated to be superior to traditional (H1) antihistamines in the treatment of pruritus (itching). The drug was abandoned because of its short in vivo half-life and hypoadrenocorticism toxicity in rats and dogs, that prevented advancing it into clinical studies.vented advancing it into clinical studies.
, JNJ-7777120 är ett läkemedel utvecklat av . Läkemedlet har antiflammatoriska effekter.
|
http://dbpedia.org/ontology/casNumber
|
459168-41-3
|
http://dbpedia.org/ontology/chEMBL
|
129198
|
http://dbpedia.org/ontology/fdaUniiCode
|
4H1AU2V37X
|
http://dbpedia.org/ontology/pubchem
|
4908365
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/JNJ-7777120.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
18687255
|
http://dbpedia.org/ontology/wikiPageLength
|
3706
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1120073178
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Hypoadrenocorticism +
, http://dbpedia.org/resource/Pruritus +
, http://dbpedia.org/resource/Receptor_antagonist +
, http://dbpedia.org/resource/Category:Chloroarenes +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Anti-inflammatory +
, http://dbpedia.org/resource/Category:Johnson_&_Johnson_brands +
, http://dbpedia.org/resource/In_vivo +
, http://dbpedia.org/resource/Category:Indoles +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/VUF-6002 +
, http://dbpedia.org/resource/Category:H4_receptor_antagonists +
, http://dbpedia.org/resource/Category:Piperazines +
, http://dbpedia.org/resource/Johnson_&_Johnson_Pharmaceutical_Research_&_Development +
, http://dbpedia.org/resource/Histamine_H4_receptor +
, http://dbpedia.org/resource/Biological_half-life +
|
http://dbpedia.org/property/alt
|
Ball-and-stick model of the JNJ-7777120 molecule
, Skeletal formula of JNJ-7777120
|
http://dbpedia.org/property/c
|
14
|
http://dbpedia.org/property/casNumber
|
459168
|
http://dbpedia.org/property/chembl
|
129198
|
http://dbpedia.org/property/chemspiderid
|
4090750
|
http://dbpedia.org/property/cl
|
1
|
http://dbpedia.org/property/h
|
16
|
http://dbpedia.org/property/image
|
JNJ-7777120-3D-spacefill.png
|
http://dbpedia.org/property/iupacName
|
5
|
http://dbpedia.org/property/iupharLigand
|
1278
|
http://dbpedia.org/property/n
|
3
|
http://dbpedia.org/property/o
|
1
|
http://dbpedia.org/property/pubchem
|
4908365
|
http://dbpedia.org/property/smiles
|
C3CNCCN3Cc[nH]c1ccc2Cl
|
http://dbpedia.org/property/stdinchi
|
1
|
http://dbpedia.org/property/stdinchikey
|
HUQJRYMLJBBEDO-UHFFFAOYSA-N
|
http://dbpedia.org/property/synonyms
|
(1-[carbonyl]-4-methylpiperazine)
|
http://dbpedia.org/property/unii
|
4
|
http://dbpedia.org/property/verifiedfields
|
changed
|
http://dbpedia.org/property/verifiedrevid
|
394360889
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Ebicite +
, http://dbpedia.org/resource/Template:Pharma-stub +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Histaminergics +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Piperazines +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:H4_receptor_antagonists +
, http://dbpedia.org/resource/Category:Indoles +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Category:Chloroarenes +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Johnson_&_Johnson_brands +
, http://dbpedia.org/resource/Category:Piperazines +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/JNJ-7777120?oldid=1120073178&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/JNJ-7777120-3D-spacefill.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/JNJ-7777120.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/JNJ-7777120 +
|
owl:sameAs |
http://yago-knowledge.org/resource/JNJ-7777120 +
, http://sr.dbpedia.org/resource/JNJ_7777120 +
, https://global.dbpedia.org/id/4nxTL +
, http://dbpedia.org/resource/JNJ-7777120 +
, http://www.wikidata.org/entity/Q6108577 +
, http://sv.dbpedia.org/resource/JNJ-7777120 +
, http://sh.dbpedia.org/resource/JNJ_7777120 +
, http://rdf.freebase.com/ns/m.04gmb1t +
|
rdf:type |
http://dbpedia.org/class/yago/Whole100003553 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Person100007846 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://umbel.org/umbel/rc/DrugProduct +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Adversary109773245 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/WikicatH4ReceptorAntagonists +
, http://dbpedia.org/class/yago/LivingThing100004258 +
, http://dbpedia.org/class/yago/Organism100004475 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Object100002684 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
|
rdfs:comment |
JNJ-7777120 was a drug being developed by … JNJ-7777120 was a drug being developed by Johnson & Johnson Pharmaceutical Research & Development which acts as a potent and selective antagonist at the histamine H4 receptor. It has anti-inflammatory effects, and has been demonstrated to be superior to traditional (H1) antihistamines in the treatment of pruritus (itching). The drug was abandoned because of its short in vivo half-life and hypoadrenocorticism toxicity in rats and dogs, that prevented advancing it into clinical studies.vented advancing it into clinical studies.
, JNJ-7777120 är ett läkemedel utvecklat av . Läkemedlet har antiflammatoriska effekter.
|
rdfs:label |
JNJ-7777120
|